Lifeboat Foundation

When an 87-year-old Californian man was wheeled into an operating room just outside Phoenix last year, the pandemic was at its height and medical protocols were being upended across the country.

A case like his would normally have required 14 or more bags of fluids to be pumped into him, but now that posed a problem.

Had he been infected with the coronavirus, tiny aerosol droplets could have escaped and infected staff, so the operating team had adopted new procedures that reduced the effectiveness of the treatment but used fewer liquids.

Now, in a medical first, researchers have injected a CRISPR drug into the blood of people born with a disease that causes fatal nerve and heart disease and shown that in three of them it nearly shut off production of toxic protein by their livers.

Novel treatment using messenger RNA sharply cuts production of mutant liver protein, although it’s too early to show patients with rare condition benefit.

👏😄We are rapidly approaching — from multiple directions of attack (pharmaceutical, nanotechnology, gene manipulation, etc) — the end of all forms of cancer, inherited diseases, even aging itself. It’s a great time to be alive IF you can live long enough to live forever(ish)! Which makes EVERY death that occurs in the meantime to be all the more of a punch to the gut and slap to the face. PARTICULARLY the 600 000 + people here in the US alone! It’s also another reason t… See More.

If the gene-editing tool CRISPR/Cas9 continues to show such promise it will herald a new era for the treatment of many genetic diseases.

In August last year, Unity released interim results showing that its drug was probably ineffective in treating study patients suffering from osteoarthritis.

Its stock price plummeted as a consequence, but Dr de Grey remains hopeful that “soon we might have drugs that actively cause these cells to die”.

While Dr de Grey is excited to see much of the life extension research he helped develop come to fruition, some thinkers are raising concerns about the implications of an extended human lifespan.

Scientists successfully treated a rare disease with the experimental gene-editing technique. It could open the door to new ways of treating more common disorders in the future.

Artificial kidneys, powerful batteries and efficient water purification are some of the future applications of a group of ultrathin materials known as MXenes. This opinion is expressed in an article in the journal Science, whose authors include one from Linköping University.

Materials that have a cross-section as thin as one or a few layers of atoms possess unusual properties due to their thickness. These properties may be high electrical conductivity, high strength or an ability to withstand heat, giving ultrathin materials a great potential for use in future technology. The most well-known material is graphene, and the hunt for other ultrathin materials, also known as two-dimensional materials, has increased in intensity since its discovery.

Graphene and many other two-dimensional materials are either semiconductors, semimetals or polarized insulators. The lack of an ultrathin metal conductor is an obstacle in the development of components based exclusively on two-dimensional materials.

Mesenchymal stem cells derived from adipose tissue appear to reverse some effects of aging in nearby somatic cells.

A new study published in the FASEB Journal shows how mesenchymal stem cells derived from adipose tissue (ADSCs) reverse some effects of aging in nearby cells.

It’s not the cells themselves, it’s what they secrete

Continue reading “How Stem Cells Promote the Health of Nearby Cells” »

Still the comic relief til about December 31, 2024. By 2035 curing everything, already in the early stages towards that.

Giovanni Traverso, an MIT assistant professor of mechanical engineering, a gastroenterologist at Brigham and Women’s Hospital, and also the senior author of the study said, that they were actively working on robots that can help provide health care services to maximize the safety, of both the patients and the health care workforce.

Traverso and his colleagues after the Covid-19 began last year, worked towards reducing interaction between the patients and the health care workers. In this process, they collaborated with Boston Dynamics in creating mobile robots that can interact with patients who waited in the emergency department.

Continue reading “Robot Doctors to Provide Health Care Services Soon” »

Move over, gene-editing proteins—there’s a smaller, cheaper, more specific genetic engineering tool on the block: DNAzymes—small DNA molecules that can function like protein enzymes.

Researchers at the University of Illinois Urbana-Champaign have developed a technique that, for the first time, allows DNAzymes to target and cut double-stranded DNA, overcoming a significant limitation of the technology. DNAzymes have been used in biosensing, DNA computing and many other applications. However, when it comes to genetic engineering applications such as gene editing or gene therapy, they have faced a challenge: DNAzymes have only been able to target sites on single-stranded DNA, while the DNA coding for genes in cells is double-stranded. The researchers published their new technique in the Journal of the American Chemical Society.

“DNAzymes have many advantages, including higher stability, smaller size and lower cost than protein enzymes. These advantages perfectly fit the requirement for genetic engineering tools,” said study leader Yi Lu, a professor of chemistry at Illinois. “No DNAzymes could alter double-stranded DNA until this work. By making that happen, we open the door for DNAzymes to enter the entire world of genetic engineering.”